FCM
MDCO

Farallon Capital Management’s Medicines Co MDCO Stock Holding History

Farallon Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,315,000
Closed -$282M – 134
2019
Q4 		$282M Buy
+3,315,000
New +$221M 1.9% 15

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Farallon Capital Management's MDCO Position: Q1 2020 in Review

Farallon Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 3,315,000 shares — an estimated $282M sold.

Farallon Capital Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $282M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Farallon Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Farallon Capital Management sold 3,315,000 Medicines Co shares in Q1 2020, an estimated $282M.
  • Farallon Capital Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Farallon Capital Management's Medicines Co position peaked at $282M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.